Teva Launches Generic Salmeterol in the U.K. To Compete With GSK's Serevent
This article was originally published in The Pink Sheet Daily
Executive Summary
The "first to market" generic salmeterol inhaler, which Teva is pricing at a 15% discount to Serevent, might help to pave the way for a much more lucrative opportunity - generic Advair.